Complete Filing Data
WORK Medical Technology Group LTD reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $21.16 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean WORK Medical Technology Group LTD did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$1.1M | -$3.5M | $112.0K | $865.2K |
| Research And Development Expense | $435.3K | $302.5K | $301.6K | $183.9K |
| Other Nonoperating Income Expense | $135.4K | $578.8K | -$8.7K | -$360.4K |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $130.4K | -$453.2K | $268.1K | $1.1M |
| Operating Expenses | $4.8M | $6.9M | $3.7M | $3.8M |
| Nonoperating Income Expense | $1.4M | $379.5K | -$301.8K | $475.2K |
| Net Income Loss Attributable To Noncontrolling Interest | -$128.4K | -$48.1K | -$48.6K | $78.9K |
| Interest Expense Nonoperating | $503.5K | $557.6K | $392.7K | $353.0K |
| Income Taxes Paid | $8.1K | $10.0K | $160.2K | $340.0K |
| Income Tax Expense Benefit | $119.1K | -$125.3K | $47.0K | $169.4K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.1M | -$3.7M | $110.4K | $1.1M |
| Gross Profit | $2.3M | $2.9M | $4.1M | $4.4M |
| General And Administrative Expense | $2.3M | $4.6M | $1.9M | $2.6M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$1.3M | -$3.1M | -$204.7K | -$203.6K |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$58.7K | $136.7K | -$80.2K | -$164.3K |
| Comprehensive Income Net Of Tax | -$1.3M | -$3.2M | -$124.5K | -$39.3K |
| Government Assistance Nonoperating Income | $1.6M | $346.6K | $74.2K | |
| Deferred Income Tax Assets Net | $112.9K | $66.9K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $18.3M | $13.2M | $9.9M | $11.2M | $11.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.1M | $6.6M | $1.6M | $773.4K | $873.1K |
| Repayments Of Short Term Debt | $9.4M | $6.0M | $7.2M | ||
| Contract With Customer Liability Current | $402.4K | $625.3K | $776.2K | $359.5K | $277.6K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.5M | $4.9M | $863.9K | -$99.7K | |
| Cash And Cash Equivalents At Carrying Value | $4.1M | $6.6M | $1.6M | $731.2K | |
| Taxes Payable Current | $501.5K | $508.7K | $736.6K | ||
| Stockholders Equity Note Subscriptions Receivable | $6.3K | $6.3K | $6.3K | ||
| Retained Earnings Accumulated Deficit | $5.0M | $6.1M | $9.6M | ||
| Property Plant And Equipment Net | $10.6M | $11.4M | $6.6M | ||
| Prepaid Expense And Other Assets Current | $1.3M | $1.6M | $4.9M | ||
| Minority Interest | $2.8M | $2.9M | $1.1M | ||
| Liabilities Current | $12.0M | $20.2M | $18.9M | ||
| Liabilities And Stockholders Equity | $33.2M | $36.3M | $30.0M | ||
| Liabilities | $12.0M | $20.2M | $19.0M | ||
| Inventory Net | $2.5M | $3.2M | $4.6M | ||
| Intangible Assets Net Excluding Goodwill | $959.1K | $1.0M | $998.5K | ||
| Assets Noncurrent | $12.7M | $15.4M | $7.8M | ||
| Assets Current | $20.5M | $20.8M | $22.2M | ||
| Assets | $33.2M | $36.3M | $30.0M | ||
| Additional Paid In Capital Common Stock | $13.0M | $6.6M | $85.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$608.7K | -$408.5K | -$676.8K | ||
| Accounts Receivable Net Current | $615.8K | $1.6M | $3.3M | ||
| Accounts Payable Current | $1.7M | $1.5M | $4.0M | ||
| Accounts Payable And Other Accrued Liabilities Current | $2.9M | $3.0M | $4.4M | ||
| Inventory Write Down | $105.6K | $762.00 | $18.3K | -$117.3K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $1.3M | $9.2M | $455.4K | $2.0M |
| Net Cash Provided By Used In Operating Activities | $6.2M | -$2.2M | $2.2M | -$2.3M |
| Net Cash Provided By Used In Investing Activities | -$7.6M | -$9.1M | -$583.3K | -$1.3M |
| Net Cash Provided By Used In Financing Activities | -$898.2K | $15.7M | -$728.7K | $3.6M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$207.4K | $555.5K | -$33.9K | -$59.8K |
| Proceeds From Short Term Debt | $13.4M | $9.1M | $7.2M | |
| Payments Of Stock Issuance Costs | $376.2K | $613.0K | $1.4M | |
| Proceeds From Sale Of Property Plant And Equipment | $472.9K | $194.3K | $601.8K | |
| Proceeds From Repayments Of Related Party Debt | $5.5M | $5.9M | $13.3M | |
| Proceeds From Issuance Initial Public Offering | $2.9M | $7.4M | ||
| Payments To Acquire Intangible Assets | $33.3K | $127.9K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$194.5K | -$293.7K | -$1.3M | $194.1K |
| Increase Decrease In Operating Lease Liability | -$5.8K | -$2.0K | -$51.8K | -$5.2K |
| Increase Decrease In Inventories | -$568.7K | -$1.6M | $400.5K | -$2.1M |
| Increase Decrease In Due To Related Parties | -$1.4M | $1.8M | -$4.0M | $743.5K |
| Increase Decrease In Contract With Customer Liability | -$211.2K | -$177.0K | $52.2K | -$751.4K |
| Increase Decrease In Advance To Suppliers | -$6.0M | $1.1M | -$977.3K | $191.8K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$32.5K | -$1.5M | $1.7M | $917.3K |
| Increase Decrease In Accounts Receivable | -$1.0M | -$1.8M | $132.0K | $4.2M |
| Increase Decrease In Accounts Payable | $245.5K | -$2.6M | $864.6K | -$5.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 29.0M | 12.7M | 12.5M | 12.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 29.0M | 12.7M | 12.5M | 12.5M |
| Earnings Per Share Diluted | $-0.04 | $-0.27 | $0.01 | $0.07 |
| Earnings Per Share Basic | $-0.04 | $-0.27 | $0.01 | $0.07 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Selling Expense | $2.1M | $2.1M | $1.6M | $1.0M |
| Investment Income Interest | $181.7K | $11.7K | $25.4K | $2.0K |
| Interest Paid Net | $508.5K | $543.8K | $312.0K | $312.3K |
| Supplies | $1.2M | $4.7M | $3.5M | |
| Statutory Reserve | $899.7K | $899.7K | $887.5K | |
| Short Term Borrowings | $6.4M | $13.3M | $8.8M | |
| Proceed Loan To Related Partie | -$4.6M | -$5.7M | -$9.5M | |
| Loans To Third Parties | $1.1M | $2.7M | $1.0M | |
| Advance To Suppliers For Equipment | $1.1M | $2.9M | ||
| Provision For Doubtful Accounts | -$185.0K | $12.2K | $149.5K | $1.1M |
Most recent annual filing with the SEC: January 30, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.